MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma

BACKGROUND: Gliomas account for 75% of all primary malignant brain tumors in adults and result in high mortality. Accumulated evidence has declared the minichromosome maintenance protein complex (MCM) gene family plays a critical role in modulating the cell cycle and DNA replication stress. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shu, Yuan, Yixiao, Ren, Wenjun, Wang, Haiyu, Zhao, Zhong, Zhao, Heng, Zhao, Qizhe, Chen, Xi, Jiang, Xiulin, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713251/
https://www.ncbi.nlm.nih.gov/pubmed/36465369
http://dx.doi.org/10.3389/fonc.2022.1004324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713251/
https://www.ncbi.nlm.nih.gov/pubmed/36465369
http://dx.doi.org/10.3389/fonc.2022.1004324

Ejemplares similares